Literature DB >> 23249538

Recent developments in the study of opioid receptors.

Brian M Cox1.   

Abstract

It is now about 40 years since Avram Goldstein proposed the use of the stereoselectivity of opioid receptors to identify these receptors in neural membranes. In 2012, the crystal structures of the four members of the opioid receptor family were reported, providing a structural basis for understanding of critical features affecting the actions of opiate drugs. This minireview summarizes these recent developments in our understanding of opiate receptors. Receptor function is also influenced by amino acid substitutions in the protein sequence. Among opioid receptor genes, one polymorphism is much more frequent in human populations than the many others that have been found, but the functional significance of this single nucleotide polymorphism (SNP) has been unclear. Recent studies have shed new light on how this SNP might influence opioid receptor function. In this minireview, the functional significance of the most prevalent genetic polymorphism among the opioid receptor genes is also considered.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23249538     DOI: 10.1124/mol.112.083279

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  21 in total

1.  Synthesis and opioid receptor binding of indium (III) and [111In]-labeled macrocyclic conjugates of diprenorphine: novel ligands designed for imaging studies of peripheral opioid receptors.

Authors:  Shefali Srivastava; Emily A Fergason-Cantrell; Roger I Nahas; John R Lever
Journal:  Tetrahedron       Date:  2016-08-04       Impact factor: 2.457

2.  Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro.

Authors:  Alisa Knapman; Marina Santiago; Mark Connor
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 3.  Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).

Authors:  Alisa Knapman; Mark Connor
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

4.  Computational insights into the subtype selectivity and "message-address-efficacy" mechanisms of opioid receptors through JDTic binding and unbinding.

Authors:  Jian-Xin Cheng; Tao Cheng; Wei-Hua Li; Gui-Xia Liu; Wei-Liang Zhu; Yun Tang
Journal:  Acta Pharmacol Sin       Date:  2017-10-19       Impact factor: 6.150

5.  Pharmacologic Evidence for a Putative Conserved Allosteric Site on Opioid Receptors.

Authors:  Kathryn E Livingston; M Alexander Stanczyk; Neil T Burford; Andrew Alt; Meritxell Canals; John R Traynor
Journal:  Mol Pharmacol       Date:  2017-12-12       Impact factor: 4.436

6.  Ligand interaction, binding site and G protein activation of the mu opioid receptor.

Authors:  Xu Cui; Alexei Yeliseev; Renyu Liu
Journal:  Eur J Pharmacol       Date:  2013-02-13       Impact factor: 4.432

7.  Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.

Authors:  M S Brown; M J Hayes; L M Thornton
Journal:  J Perinatol       Date:  2014-10-30       Impact factor: 2.521

Review 8.  [Pain inhibition by opioids-new concepts].

Authors:  C Stein
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

Review 9.  β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia.

Authors:  Kirsten M Raehal; Laura M Bohn
Journal:  Handb Exp Pharmacol       Date:  2014

10.  G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons.

Authors:  Jo-Hao Ho; Edward L Stahl; Cullen L Schmid; Sarah M Scarry; Jeffrey Aubé; Laura M Bohn
Journal:  Sci Signal       Date:  2018-08-07       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.